Inventor · disambiguated record
Michael Burgess
Also filed as: BURGESS MICHAEL · BURGESS MICHAEL F · BURGESS MICHAEL FRANS
1 granted patent·13 pending applications·0 citations·filing 2006–2024
13Inventor score
Files withOTTAWA HOSPITAL RES INST4JUNO THERAPEUTICS INC3BRISTOL MYERS SQUIBB CO2CELGENE CORP2CHILDRENS HOSPITAL OF EASTERN ONTARIO RES INSTITUTE INC1
Top patents by PatentIndex Score
14 records- 0166US2024285762A1Cell therapy for treating systemic autoimmune diseasesJUNO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0263US2024229069A9Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2023·Application pending·0 cites
- 0360US2021371522A1Cd47 antibodies and methods of use thereofCELGENE CORP·Filed 2021·Application pending·0 cites
- 0453US11802292B2Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2019·Granted Oct 31, 2023·0 cites·50 claims
- 0551US2010029676A1T315a and f317i mutations of bcr-abl kinase domainSAWYERS CHARLES L·Filed 2006·Application pending·0 cites
- 0649US2023057602A1Methods of treatment with antibodies against bcma and cd3BRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 0749US2022380799A1Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2019·Application pending·0 cites
- 0847US2020255515A1Cd47 antibodies and methods of use thereofCELGENE CORP·Filed 2017·Application pending·0 cites
- 0947US2022056480A1Modified orthopoxvirus vectorsOTTAWA HOSPITAL RES INST·Filed 2019·Application pending·0 cites
- 1045US2023190798A1Cd19-directed chimeric antigen receptor t cell compositions and methods and uses thereofJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1145US2023087953A1Bcma-directed chimeric antigen receptor t cell compositions and methods and uses thereofJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1239US2022152168A1Sequential heterologous boost oncolytic viral immunotherapyCHILDRENS HOSPITAL OF EASTERN ONTARIO RES INSTITUTE INC·Filed 2020·Application pending·0 cites
- 1339US2019135905A1Compositions and methods for treating tauopathiesBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1438US2022160800A1Methods for inducing an immune response against neoantigensTURNSTONE BIOLOGICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Burgess files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →